Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29, 2024 /PRNewswire/ — Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 million in Series B financing. This additional funding will […] L'articolo Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI proviene da La Ragione.

CONTINUA A LEGGERE